Clinical Trials Logo

Warts clinical trials

View clinical trials related to Warts.

Filter by:
  • Not yet recruiting  
  • « Prev · Page 2

NCT ID: NCT05057663 Not yet recruiting - Plantar Wart Clinical Trials

Intralesional Treatment of Plantar Wart

Start date: November 1, 2021
Phase: N/A
Study type: Interventional

Group 1; intralesional injection of bleomycin in plantar wart. Group 2; intralesional injection of 5-fluorouracil in plantar wart

NCT ID: NCT04654091 Not yet recruiting - Plantar Wart Clinical Trials

Cryotherapy VS. Nitric-zinc Complex in the Treatment of Plantar Warts.

Start date: January 1, 2021
Phase: N/A
Study type: Interventional

Plantar warts are benign skin lesions caused by human papillomavirus (HPV).There are several treatment methods for this illness, but none of them can heal all patients. Cryotherapy using liquid nitrogen is one of the most common local treatments. In this study, we will compare the effectiveness of cryotherapy with liquid nitrogen with the association of organic acids and nitric acid (nitric-zinc complex). In addition, as secondary objectives have been defined: 1) know the number of applications necessary for each treatment to achieve the complete resolution of the plantar wart, in order to compare the healing times between each treatment and establish which treatment is faster, 2) analyze the influence of the HPV biotype, the location of the lesion and the time of evolution in the response to the different treatments, and 3) Compare the ultrasound signs of plantar warts with the ultrasound signs of healthy skin after the resolution of the process.

NCT ID: NCT04290572 Not yet recruiting - Flat Wart Clinical Trials

Efficacy and Safety of Oral Isotretinoin for the Treatment of Facial Recalcitrant Flat Warts

Start date: March 15, 2020
Phase: Phase 3
Study type: Interventional

Randomized clinical trial to compare the efficacy of different doses of oral isotretinoin 10 mg/day, 20 mg/day and 30 mg/day during 12 weeks for the treatment of facial recalcitrant flat warts. The primary endpoint will be the proportion of participants with total remission of facial flat warts at the end of the intervention in the three arms of the clinical trial.

NCT ID: NCT04288817 Not yet recruiting - Common Wart Clinical Trials

Efficacy of Cryotherapy Combined With Intralesional Tuberculin PPD Versus Intralesional Tuberculin PPD in Treatment of Multiple Common Warts

Start date: March 1, 2020
Phase: Phase 3
Study type: Interventional

The investigate the efficacy and safety of combined 'cryo-immuno-therapy' versus intralesional tuberculin purified protein derivative (PPD) antigen immunotherapy alone for multiple common warts

NCT ID: NCT03477448 Not yet recruiting - Warts Clinical Trials

The Efficacy of Intra-lesional Bleomycin Versus Intra-lesional Purified Protein Derivative in Treatment of Palmoplantar Warts

Start date: April 1, 2018
Phase: Phase 4
Study type: Interventional

- Warts are common viral infections on the skin and are prevalent worldwide. Warts are caused by the human Papilloma virus (HPV), which has more than 100 strains; some of them are known to be premalignant. Although warts can appear at any age, they are more common in children and adolescents. The prognosis of warts cannot be predicted. In some patients they may spontaneously disappear, whereas others show persistence and progression with spreading to other body sites, leading to physical and emotional distress to the patients. - Factors that increase the risk include use of public showers, working with meat, eczema, and a low immune system . The virus is believed to enter the body through skin that has been damaged slightly . A number of types exist including: common warts, plantar warts, filiform warts, and genital warts . Genital warts are often sexually transmitted.

NCT ID: NCT03166137 Not yet recruiting - Common Warts Clinical Trials

Carbon Dioxide Laser and Cryotherapy in Treatment of Warts

Start date: August 1, 2017
Phase: N/A
Study type: Interventional

Viral warts are common skin conditions seen in both children and adults. Human papilloma virus is responsible for verrucae. Cutaneous manifestation of the human papillomavirus, are extremely common particularly on the hands and feet. Warts can induce hard, thickened skin, black pinpoints, pain or tenderness with significant morbidity for the patients.

NCT ID: NCT03153566 Not yet recruiting - Genital Wart Clinical Trials

Comparison Between Tuberculin Vaccine and Cryotherapy in Genital Wart Patients

Start date: June 1, 2017
Phase: Phase 3
Study type: Interventional

Cutaneous and genital warts are common dermatological conditions caused by Human Papilloma Virus. Although it is a benign condition it causes disfigurement, has tendency to collect, can be transmitted to others, this makes adequate and timely treatment important, while many warts are resolve spontaneously over several years, most patients seek treatment because the warts are unsightly and often tender or painful.

NCT ID: NCT01520194 Not yet recruiting - Clinical trials for Female Genital Warts

The Psychosocial and Economic Burden of Genital Warts

GWburden
Start date: January 2012
Phase: N/A
Study type: Observational

Considering the importance of HPV(human papilomavirus) and related diseases in Brazil, and the lack of studies about both the economic and the psychosocial burden of these diseases, BEMFAM, a Brazilian non-governmental organization that provides reproductive health services and technical support to local governments proposes a study to measure the psychosocial and economic burden of genital warts.